The global automated radiosynthesis module market size was estimated at around US$ 27.92 Million in 2020, and is projected to reach $ 45.93 Million by 2030, registering a CAGR of 5.1% from 2021 to 2030.
The global automated radiosynthesis module market size was estimated at around US$ 27.92 Million in 2020, and is projected to reach $ 45.93 Million by 2030, registering a CAGR of 5.1% from 2021 to 2030.
Automated radiosynthesis modules can be defined as automated equipment that is used to formulate the radioactive isotope with a tracer molecule suitable for use in diagnostic and therapeutic processes. These techniques use diagnostic tools such as PET and SPECT that are widely adopted globally to reduce the rapidly increasing chronic diseases. This equipment uses PET radiopharmaceuticals with short life-time radioactive isotopes that are manufactured using fully automated radio synthesis process. The radiopharmaceuticals are incorporated in the PET/CT/SPECT scanners to improve the utility of tomographic imaging diagnostics methods that are available commercially.
Full Report is Ready | Request Sample of This Report @ https://qyresearchmedical.com/sample/112591
The COVID-19 pandemic was an unprecedented global public health challenge and was anticipated to had negative impact on the automated radio synthesis module market owing to decline in number of patients in hospitals & clinics for surgery as well as for radiation therapy, as patients suffering from chronic diseases such as cancer are more vulnerable to COVID-19 infection, which lead to decline in demand of automated radio synthesis module. However, owing to the travel restrictions and lock down, the supply chain was severely impacted, since production was halted. Furthermore, due to the outbreak of COVID-19, most markets had experienced a decline in demand, especially in the automated radio synthesis module market.
Automated radiosynthesis module is expected to exhibit significant market growth during the forecast period, owing to rise in the incidence of chronic diseases. The key factors that drive growth of the market are need to enhance the flexibility of production of the wide variety of PET-tracers (>1800) and increased usage in diverse applications within diagnostic and therapeutic processes. However, high cost of installation and servicing of automated radiosynthesis module restricts the market growth. Conversely, funding and grants provided by government as well as private institutions encourage the adoption of automated radiosynthesis module for various applications that is expected to create immense market opportunities for the manufacturers.
Scope of the Report
|
Report Coverage |
Details |
|
Market Size in 2020 |
USD 27.92 Million |
|
Revenue Forecast by 2030 |
USD 45.93 Million |
|
Base Year |
2021 |
|
Forecast Data |
2022 to 2030 |
The automated radiosynthesis module market is segmented on the basis ofregion. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Full Report is Ready | Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112591/2900
COVID-19 Impact
Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans.
After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On March 11, 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, only a few vaccines received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns.
The overall impact of COVID-19 remained negative on the automated radiosynthesis module market owing to decline in number of patients in hospitals & clinics for surgery as well as for radiation therapy, as patients suffering from chronic diseases such as cancer are more vulnerable to COVID-19 infection, which lead to decline in demand of automated radiosynthesis module. However, owing to the travel restrictions and lockdown, the supply chain was severely impacted, since production was halted. Furthermore, due to the outbreak of COVID-19, most markets have experienced a decline in demand, especially in the automated radiosynthesis module market.
Region segment review
By region, the automated radiosynthesis module market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period owing to improved healthcare infrastructure along with rise in adoption rate of automated radiosynthesis module in various diagnostics and the therapeutic processes.
This report provides comprehensive competitive analysis and profiles of prominent market players such as key players operating in GE Healthcare, Siemens Healthcare, IBA Radiopharma Solutions, Optimized Radiochemical Applications, Synthra GmbH, Eckert& Ziegler Group, Sofie Biosciences, Trasis S.A, Scintomics GmbH, RaytestIsotopenmessgerte GmbH.
Key Benefits For Stakeholders
- The study offers a detailed analysis along with automated radiosynthesis module market dynamics.
- A quantitative analysis of the current trends market and future estimations from 2021 to 2030 is provided, enabling all the stakeholders to capitalize the prevailing and emerging opportunities of the automated radiosynthesis module market.
- Key market players and their market share analysis in studied in the report.
- Strategic analysis of the key leaders and their business strategies within the automated radiosynthesis module market are provided, which assist stakeholders to make more informed business decisions.
- Porter’s five forces analysis examines the competitive structure of the global market and also provides a deeper understanding of the influence factors for market entry and market expansion.
Key Market Segments
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- North America
- KEY PLAYERS
- Eckert & Ziegler Group
- GE Healthcare
- IBA Radiopharma Solutions
- Optimized Radiochemical Applications
- RaytestIsotopenmessgerte GmbH
- Scintomics GmbH
- Siemens Healthcare
- Sofie Biosciences
- Synthra GmbH
- Trasis S.A
Full Report is Ready | Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112591/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/